Precision Biosciences (DTIL) EBT Growth (3y) (2021 - 2026)
Precision Biosciences (DTIL) EBT Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | 9.34% |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn | 40.43% |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn | 12.01% |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn | -1.05% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn | 86.16% |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn | 48.67% |
| 10 | Precision Biosciences | 181.06 Mn | 152.77 Mn | - | 10.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.30% |
| Dec 31, 2025 | 44.73% |
| Sep 30, 2025 | -25.36% |
| Jun 30, 2025 | 14.81% |
| Mar 31, 2025 | 14.66% |
| Dec 31, 2024 | 8.13% |
| Sep 30, 2024 | -10.02% |
| Jun 30, 2024 | -7.31% |
| Mar 31, 2024 | 45.70% |
| Dec 31, 2023 | 17.17% |
| Sep 30, 2023 | 27.96% |
| Jun 30, 2023 | 40.00% |
| Mar 31, 2023 | 26.19% |
| Dec 31, 2022 | 16.87% |
| Sep 30, 2022 | 15.74% |
| Jun 30, 2022 | -11.13% |
| Mar 31, 2022 | -14.78% |
| Dec 31, 2021 | -24.30% |
| Sep 30, 2021 | -31.38% |
| Jun 30, 2021 | 54.01% |